Cortiment Dosage/Direction for Use

Posology: Adults: The recommended daily dose for induction of remission is one 9 mg tablet in the morning, for up to 8 weeks.
When treatment is discontinued, it may be useful to gradually reduce the dose (for more details on treatment discontinuation, see PRECAUTIONS).
Paediatric population: The safety and efficacy of Budesonide (CORTIMENT) tablets in children aged 0-18 years have not yet been established. No data are available, therefore the use in paediatric population is not recommended until further data become available.
Elderly: No special dose adjustment is recommended. However, experience of the use of Budesonide (CORTIMENT) in the elderly is limited.
Hepatic and renal impairment population: Budesonide (CORTIMENT) 9 mg was not studied in patients with hepatic and renal impairment, therefore caution should be exercised in the administration and monitoring of the product in these patients (see PRECAUTIONS).
Method of administration: One tablet of Budesonide (CORTIMENT) 9 mg is taken orally in the morning, with or without food. The tablet should be swallowed with a glass of water and must not be broken, crushed or chewed as the film coating is intended to ensure a prolonged release.